I hope phase 3&4 trials are impressed with haste at minimum number of patients 300+ because of the excellent safety profile, to get FDA to approve quicker and help patients in the process,its only flu virus after all, no engineering etc,with terrific cancer fighting properties,
Viralytics already have established dose rates, delivery options, safety, compatibility, lives being lost waiting... sigh
- Forums
- ASX - By Stock
- VLA
- AGM notes from a non-medic.
AGM notes from a non-medic., page-5
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online